Effect of chicoridin on ulcerative colitis
Phase 3
Recruiting
- Conditions
- lcerative colitis.Ulcerative colitis
- Registration Number
- IRCT20190712044182N2
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Patients 18-80 years old with mild to moderate ulcerative colitis based on Simple Clinical Colitis Activity Index
Exclusion Criteria
hospital admission
significant comorbidities including liver or kidney diseases
pregnancy
lactating women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy of chicoridin in improvement of ulcerative colitis symptoms and patients' self-reported well-being according to the Simple Clinical Colitis Activity Index” (SCCAI). Timepoint: 4weeks and 8 weeks after the intervention onset. Method of measurement: Interviews with patients and complete table of Simple Clinical Colitis Activity Index” (SCCAI).
- Secondary Outcome Measures
Name Time Method